These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 22926506)

  • 1. Magnetic resonance lymphography of sentinel lymph nodes in patients with breast cancer using superparamagnetic iron oxide: a feasibility study.
    Shiozawa M; Kobayashi S; Sato Y; Maeshima H; Hozumi Y; Lefor AT; Kurihara K; Sata N; Yasuda Y
    Breast Cancer; 2014 Jul; 21(4):394-401. PubMed ID: 22926506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPIO-enhanced magnetic resonance imaging for the detection of metastases in sentinel nodes localized by computed tomography lymphography in patients with breast cancer.
    Motomura K; Ishitobi M; Komoike Y; Koyama H; Noguchi A; Sumino H; Kumatani Y; Inaji H; Horinouchi T; Nakanishi K
    Ann Surg Oncol; 2011 Nov; 18(12):3422-9. PubMed ID: 21607775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-operative sentinel lymph node localization in breast cancer with superparamagnetic iron oxide MRI: the SentiMAG Multicentre Trial imaging subprotocol.
    Pouw JJ; Grootendorst MR; Bezooijen R; Klazen CA; De Bruin WI; Klaase JM; Hall-Craggs MA; Douek M; Ten Haken B
    Br J Radiol; 2015; 88(1056):20150634. PubMed ID: 26492466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple assessment of sentinel lymph node metastasis in early breast cancer using preoperative CTLG, intraoperative fluorescence navigation and OSNA.
    Mokhtar M; Tadokoro Y; Nakagawa M; Morimoto M; Takechi H; Kondo K; Tangoku A
    Breast Cancer; 2016 Mar; 23(2):202-10. PubMed ID: 25069434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-Enhanced Ultrasound Biopsy of Sentinel Lymph Nodes in Patients with Breast Cancer: Implications for Axillary Metastases and Conservation.
    Cox K; Weeks J; Mills P; Chalmers R; Devalia H; Fish D; Sever A
    Ann Surg Oncol; 2016 Jan; 23(1):58-64. PubMed ID: 25990967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results.
    Kimura K; Tanigawa N; Matsuki M; Nohara T; Iwamoto M; Sumiyoshi K; Tanaka S; Takahashi Y; Narumi Y
    Breast Cancer; 2010 Oct; 17(4):241-6. PubMed ID: 19575282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superparamagnetic iron oxide-enhanced MRI at 3 T for accurate axillary staging in breast cancer.
    Motomura K; Izumi T; Tateishi S; Tamaki Y; Ito Y; Horinouchi T; Nakanishi K
    Br J Surg; 2016 Jan; 103(1):60-9. PubMed ID: 26572241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer.
    Rubio IT; Diaz-Botero S; Esgueva A; Rodriguez R; Cortadellas T; Cordoba O; Espinosa-Bravo M
    Eur J Surg Oncol; 2015 Jan; 41(1):46-51. PubMed ID: 25466980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradermal microbubbles and contrast-enhanced ultrasound (CEUS) is a feasible approach for sentinel lymph node identification in early-stage breast cancer.
    Xie F; Zhang D; Cheng L; Yu L; Yang L; Tong F; Liu H; Wang S; Wang S
    World J Surg Oncol; 2015 Nov; 13():319. PubMed ID: 26585236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rate of solitary sentinel node metastases identification by fluorescence-guided lymphatic imaging in breast cancer.
    Hirche C; Mohr Z; Kneif S; Murawa D; Hünerbein M
    J Surg Oncol; 2012 Feb; 105(2):162-6. PubMed ID: 21882198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast sentinel lymph node mapping at CT lymphography with iopamidol: preliminary experience.
    Suga K; Yuan Y; Okada M; Matsunaga N; Tangoku A; Yamamoto S; Oka M
    Radiology; 2004 Feb; 230(2):543-52. PubMed ID: 14699178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative dynamic lymphoscintigraphy predicts sentinel lymph node metastasis in patients with early breast cancer.
    Nakashima K; Kurebayashi J; Sonoo H; Tanaka K; Ikeda M; Shiiki S; Yamamoto Y; Nomura T; Sohda M; Seki M; Miyake A; Moriya T; Sadahira Y; Mimura H; Fukunaga M
    Breast Cancer; 2010; 17(1):17-21. PubMed ID: 19466508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node detection using magnetic resonance lymphography with conventional gadolinium contrast agent in breast cancer: a preliminary clinical study.
    Li C; Meng S; Yang X; Zhou D; Wang J; Hu J
    BMC Cancer; 2015 Apr; 15():213. PubMed ID: 25886638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
    Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sentinel lymph node biopsy in breast cancer.
    Weerts JM; Maweja S; Tamigneaux I; Dallemagne B; Jourdan JL; Markiewicz S; Monami B; Wahlen Ch; Lastra M; Hénon V; Gomez P; Lilet H; Dwelshauwers J; Graas MP; Focan Ch; Lipczei B; Abraham F; Jehaes C
    Acta Chir Belg; 2002 Apr; 102(2):110-3. PubMed ID: 12051082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS).
    Reyna C; Kiluk JV; Frelick A; Khakpour N; Laronga C; Lee MC
    J Surg Oncol; 2015 Jun; 111(7):813-8. PubMed ID: 25753101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node pressure in breast cancer.
    Nathanson SD; Mahan M
    Ann Surg Oncol; 2011 Dec; 18(13):3791-6. PubMed ID: 21626079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
    Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
    Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.